| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |